Review

NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues

B Perbal

Laboratoire d' Oncologie Virale et Moléculaire, UFR de Biochimie, Université Paris 7-D. Diderot, 2 Place Jussieu, 75 005 Paris, France

Correspondence to:
Professor Perbal bernard.perbal{at}wanadoo.fr

The CCN family of genes presently consists of six distinct members encoding proteins that participate in fundamental biological processes such as cell proliferation, attachment, migration, differentiation, wound healing, angiogenesis, and several pathologies including fibrosis and tumorigenesis. Whereas CYR61 and CTGF were reported to act as positive regulators of cell growth, NOV (nephroblastoma overexpressed) provided the first example of a CCN protein with negative regulatory properties and the first example of aberrant expression being associated with tumour development. The subsequent discovery of the ELM1, rCOP1, and WISP proteins has broadened the variety of functions attributed to the CCN proteins and has extended previous observations to other biological systems. This review discusses fundamental questions regarding the regulation of CCN gene expression in normal and pathological conditions, and the structural basis for their specific biological activity. After discussing the role of nov and other CCN proteins in the development of a variety of different tissues such as kidney, nervous system, muscle, cartilage, and bone, the altered expression of the CCN proteins in various pathologies is discussed, with an emphasis on the altered expression of nov in many different tumour types such as Wilms's tumour, renal cell carcinomas, prostate carcinomas, osteosarcomas, chondrosarcomas, adrenocortical carcinomas, and neuroblastomas. The possible use of nov as a tool for molecular medicine is also discussed. The variety of biological functions attributed to the CCN proteins has led to the proposal of a model in which physical interactions between the amino and carboxy portions of the CCN proteins modulate their biological activity and ensure a proper balance of positive and negative signals through interactions with other partners. In this model, disruption of the secondary structure of the CCN proteins induced by deletions of either terminus is expected to confer on the truncated polypeptide constitutive positive or negative activities.

Key Words: cancer • differentiation • signalling • development • angiogenesis • fibrosis • ctgf • cyr61 • wisp • CCN

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• HASSID, V. J., ORLANDO, F. A., AWAD, Z. T., TAN, D., KHOURY, T., AHMED, B. H., ALRAWI, S. J. (2009). Genetic and Molecular Abnormalities in Cholangiocarcinogenesis. Anticancer Res 29: 1151-1156 [Abstract] [Full Text]  
• Hirschfeld, M., zur Hausen, A., Bettendorf, H., Jager, M., Stickeler, E. (2009). Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer. Cancer Res. 69: 2082-2090 [Abstract] [Full Text]  
• Bennewith, K. L., Huang, X., Ham, C. M., Graves, E. E., Erler, J. T., Kambham, N., Feazell, J., Yang, G. P., Koong, A., Giaccia, A. J. (2009). The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth. Cancer Res. 69: 775-784 [Abstract] [Full Text]  
• Jin, Y., Kim, H. P., Cao, J., Zhang, M., Ifedigbo, E., Choi, A. M. K. (2009). Caveolin-1 regulates the secretion and cytoprotection of Cyr61 in hyperoxic cell death. FASEB J. 23: 341-350 [Abstract] [Full Text]  
• He, S., Chen, Y., Khankan, R., Barron, E., Burton, R., Zhu, D., Ryan, S. J., Oliver, N., Hinton, D. R. (2008). Connective Tissue Growth Factor as a Mediator of Intraocular Fibrosis. IOVS 49: 4078-4088 [Abstract] [Full Text]  
• Walsh, C. T., Stupack, D., Brown, J. H. (2008). G Protein-Coupled Receptors Go Extracellular: RhoA Integrates the Integrins. Mol. Interv. 8: 165-173 [Abstract] [Full Text]  
• Huang, W., Zhang, Y., Varambally, S., Chinnaiyan, A. M., Banerjee, M., Merajver, S. D., Kleer, C. G. (2008). Inhibition of CCN6 (Wnt-1-Induced Signaling Protein 3) Down-Regulates E-Cadherin in the Breast Epithelium through Induction of Snail and ZEB1. Am. J. Pathol. 172: 893-904 [Abstract] [Full Text]  
• Vallacchi, V., Daniotti, M., Ratti, F., Di Stasi, D., Deho, P., De Filippo, A., Tragni, G., Balsari, A., Carbone, A., Rivoltini, L., Parmiani, G., Lazar, N., Perbal, B., Rodolfo, M. (2008). CCN3/Nephroblastoma Overexpressed Matricellular Protein Regulates Integrin Expression, Adhesion, and Dissemination in Melanoma. Cancer Res. 68: 715-723 [Abstract] [Full Text]  
• Perbal, B., Zuntini, M., Zambelli, D., Serra, M., Sciandra, M., Cantiani, L., Lucarelli, E., Picci, P., Scotlandi, K. (2008). Prognostic Value of CCN3 in Osteosarcoma. Clin. Cancer Res. 14: 701-709 [Abstract] [Full Text]  
• Deng, Y.-Z., Chen, P.-P., Wang, Y., Yin, D., Koeffler, H. P., Li, B., Tong, X.-J., Xie, D. (2007). Connective Tissue Growth Factor Is Overexpressed in Esophageal Squamous Cell Carcinoma and Promotes Tumorigenicity through -Catenin-T-cell Factor/Lef Signaling. J. Biol. Chem. 282: 36571-36581 [Abstract] [Full Text]  
• Kikuchi, R., Tsuda, H., Kanai, Y., Kasamatsu, T., Sengoku, K., Hirohashi, S., Inazawa, J., Imoto, I. (2007). Promoter Hypermethylation Contributes to Frequent Inactivation of a Putative Conditional Tumor Suppressor Gene Connective Tissue Growth Factor in Ovarian Cancer. Cancer Res. 67: 7095-7105 [Abstract] [Full Text]  
• Yan, X., Baxter, R. C., Perbal, B., Firth, S. M. (2006). The Aminoterminal Insulin-Like Growth Factor (IGF) Binding Domain of IGF Binding Protein-3 Cannot Be Functionally Substituted by the Structurally Homologous Domain of CCN3. Endocrinology 147: 5268-5274 [Abstract] [Full Text]  
• McCallum, L., Price, S., Planque, N., Perbal, B., Pierce, A., Whetton, A. D., Irvine, A. E. (2006). A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood 108: 1716-1723 [Abstract] [Full Text]  
• Chen, Y., Ni, H., Ma, X.-H., Hu, S.-J., Luan, L.-M., Ren, G., Zhao, Y.-C., Li, S.-J., Diao, H.-L., Xu, X., Zhao, Z.-A., Yang, Z.-M. (2006). Global analysis of differential luminal epithelial gene expression at mouse implantation sites.. J Mol Endocrinol 37: 147-161 [Abstract] [Full Text]  
• Chien, W., Yin, D., Gui, D., Mori, A., Frank, J. M., Said, J., Kusuanco, D., Marchevsky, A., McKenna, R., Koeffler, H. P. (2006). Suppression of Cell Proliferation and Signaling Transduction by Connective Tissue Growth Factor in Non-Small Cell Lung Cancer Cells. Mol Cancer Res 4: 591-598 [Abstract] [Full Text]  
• Gellhaus, A., Schmidt, M., Dunk, C., Lye, S. J., Kimmig, R., Winterhager, E. (2006). Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associatedwith pre-eclampsia. Mol Hum Reprod 12: 389-399 [Abstract] [Full Text]  
• Huang, Z., Taylor, L., Liu, B., Yu, J., Polgar, P. (2006). Modulation by bradykinin of angiotensin type 1 receptor-evoked RhoA activation of connective tissue growth factor expression in human lung fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L1291-L1299 [Abstract] [Full Text]  
• Aikawa, T., Gunn, J., Spong, S. M., Klaus, S. J., Korc, M. (2006). Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Molecular Cancer Therapeutics 5: 1108-1116 [Abstract] [Full Text]  
• Luo, X., Ding, L., Chegini, N. (2006). CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-{beta} and regulation by TGF-{beta} in leiomyoma and myometrial smooth muscle cells. Mol Hum Reprod 12: 245-256 [Abstract] [Full Text]  
• Tong, Z.-Y., Brigstock, D. R (2006). Intrinsic biological activity of the thrombospondin structural homology repeat in connective tissue growth factor.. J Endocrinol 188: R1-R8 [Abstract] [Full Text]  
• Burgess, J. K., Ge, Q., Poniris, M. H., Boustany, S., Twigg, S. M., Black, J. L., Johnson, P. R. A. (2006). Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L153-L161 [Abstract] [Full Text]  
• Grotendorst, G. R., Duncan, M. R. (2005). Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 19: 729-738 [Abstract] [Full Text]  
• Lin, C. G., Chen, C.-C., Leu, S.-J., Grzeszkiewicz, T. M., Lau, L. F. (2005). Integrin-dependent Functions of the Angiogenic Inducer NOV (CCN3): IMPLICATION IN WOUND HEALING. J. Biol. Chem. 280: 8229-8237 [Abstract] [Full Text]  
• Kutz, W. E., Gong, Y., Warman, M. L. (2005). WISP3, the Gene Responsible for the Human Skeletal Disease Progressive Pseudorheumatoid Dysplasia, Is Not Essential for Skeletal Function in Mice. Mol. Cell. Biol. 25: 414-421 [Abstract] [Full Text]  
• Chien, W., Kumagai, T., Miller, C. W., Desmond, J. C., Frank, J. M., Said, J. W., Koeffler, H. P. (2004). Cyr61 Suppresses Growth of Human Endometrial Cancer Cells. J. Biol. Chem. 279: 53087-53096 [Abstract] [Full Text]  
• Chen, Y., Abraham, D. J., Shi-wen, X., Pearson, J. D., Black, C. M., Lyons, K. M., Leask, A. (2004). CCN2 (Connective Tissue Growth Factor) Promotes Fibroblast Adhesion to Fibronectin. Mol. Biol. Cell 15: 5635-5646 [Abstract] [Full Text]  
• Chen, N., Leu, S.-J., Todorovic, V., Lam, S. C.-T., Lau, L. F. (2004). Identification of a Novel Integrin {alpha}v{beta}3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells. J. Biol. Chem. 279: 44166-44176 [Abstract] [Full Text]  
• Leu, S.-J., Chen, N., Chen, C.-C., Todorovic, V., Bai, T., Juric, V., Liu, Y., Yan, G., Lam, S. C.-T., Lau, L. F. (2004). Targeted Mutagenesis of the Angiogenic Protein CCN1 (CYR61): SELECTIVE INACTIVATION OF INTEGRIN {alpha}6{beta}1-HEPARAN SULFATE PROTEOGLYCAN CORECEPTOR-MEDIATED CELLULAR FUNCTIONS. J. Biol. Chem. 279: 44177-44187 [Abstract] [Full Text]  
• Williams, S. S., Mear, J. P., Liang, H.-C., Potter, S. S., Aronow, B. J., Colbert, M. C. (2004). Large-scale reprogramming of cranial neural crest gene expression by retinoic acid exposure. Physiol. Genomics 19: 184-197 [Abstract] [Full Text]  
• French, D. M., Kaul, R. J., D'Souza, A. L., Crowley, C. W., Bao, M., Frantz, G. D., Filvaroff, E. H., Desnoyers, L. (2004). WISP-1 Is an Osteoblastic Regulator Expressed During Skeletal Development and Fracture Repair. Am. J. Pathol. 165: 855-867 [Abstract] [Full Text]  
• Gellhaus, A., Dong, X., Propson, S., Maass, K., Klein-Hitpass, L., Kibschull, M., Traub, O., Willecke, K., Perbal, B., Lye, S. J., Winterhager, E. (2004). Connexin43 Interacts with NOV: A POSSIBLE MECHANISM FOR NEGATIVE REGULATION OF CELL GROWTH IN CHORIOCARCINOMA CELLS. J. Biol. Chem. 279: 36931-36942 [Abstract] [Full Text]  
• Hilfiker-Kleiner, D., Kaminski, K., Kaminska, A., Fuchs, M., Klein, G., Podewski, E., Grote, K., Kiian, I., Wollert, K. C., Hilfiker, A., Drexler, H. (2004). Regulation of Proangiogenic Factor CCN1 in Cardiac Muscle: Impact of Ischemia, Pressure Overload, and Neurohumoral Activation. Circulation 109: 2227-2233 [Abstract] [Full Text]  
• Trackman, P. C., Kantarci, A. (2004). CONNECTIVE TISSUE METABOLISM AND GINGIVAL OVERGROWTH. CROBM 15: 165-175 [Abstract] [Full Text]  
• Hennebold, J. D. (2004). Characterization of the ovarian transcriptome through the use of differential analysis of gene expression methodologies. Hum Reprod Update 10: 227-239 [Abstract] [Full Text]  
• Mercurio, S., Latinkic, B., Itasaki, N., Krumlauf, R., Smith, J. C. (2004). Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131: 2137-2147 [Abstract] [Full Text]  
• Croci, S., Landuzzi, L., Astolfi, A., Nicoletti, G., Rosolen, A., Sartori, F., Follo, M. Y., Oliver, N., De Giovanni, C., Nanni, P., Lollini, P.-L. (2004). Inhibition of Connective Tissue Growth Factor (CTGF/CCN2) Expression Decreases the Survival and Myogenic Differentiation of Human Rhabdomyosarcoma Cells. Cancer Res. 64: 1730-1736 [Abstract] [Full Text]  
• Hinton, D. R., Spee, C., He, S., Weitz, S., Usinger, W., LaBree, L., Oliver, N., Lim, J. I. (2004). Accumulation of NH2-Terminal Fragment of Connective Tissue Growth Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy. Diabetes Care 27: 758-764 [Abstract] [Full Text]  
• Minato, M., Kubota, S., Kawaki, H., Nishida, T., Miyauchi, A., Hanagata, H., Nakanishi, T., Takano-Yamamoto, T., Takigawa, M. (2004). Module-Specific Antibodies against Human Connective Tissue Growth Factor: Utility for Structural and Functional Analysis of the Factor as Related to Chondrocytes. J Biochem 135: 347-354 [Abstract] [Full Text]  
• Mason, H. R., Lake, A. C., Wubben, J. E., Nowak, R. A., Castellot, J. J. Jr (2004). The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Mol Hum Reprod 10: 181-187 [Abstract] [Full Text]  
• Mason, H. R., Grove-Strawser, D., Rubin, B. S., Nowak, R. A., Castellot, J. J. Jr. (2004). Estrogen Induces CCN5 Expression in the Rat Uterus in Vivo. Endocrinology 145: 976-982 [Abstract] [Full Text]  
• Bruno, L., Hoffmann, R., McBlane, F., Brown, J., Gupta, R., Joshi, C., Pearson, S., Seidl, T., Heyworth, C., Enver, T. (2004). Molecular Signatures of Self-Renewal, Differentiation, and Lineage Choice in Multipotential Hemopoietic Progenitor Cells In Vitro. Mol. Cell. Biol. 24: 741-756 [Abstract] [Full Text]  
• Sakamoto, S., Yokoyama, M., Prakash, K., Tsuruha, J.-I., Masamoto, S., Getzenberg, R. H., Kakehi, Y. (2003). Development of Quantitative Detection Assays for CYR61 as a New Marker for Benign Prostatic Hyperplasia. J Biomol Screen 8: 701-711 [Abstract]  
• Kunz, M., Moeller, S., Koczan, D., Lorenz, P., Wenger, R. H., Glocker, M. O., Thiesen, H.-J., Gross, G., Ibrahim, S. M. (2003). Mechanisms of Hypoxic Gene Regulation of Angiogenesis Factor Cyr61 in Melanoma Cells. J. Biol. Chem. 278: 45651-45660 [Abstract] [Full Text]  
• Iwanciw, D., Rehm, M., Porst, M., Goppelt-Struebe, M. (2003). Induction of Connective Tissue Growth Factor by Angiotensin II: Integration of Signaling Pathways. Arterioscler. Thromb. Vasc. Bio. 23: 1782-1787 [Abstract] [Full Text]  
• Leu, S.-J., Liu, Y., Chen, N., Chen, C.-C., Lam, S. C.-T., Lau, L. F. (2003). Identification of a Novel Integrin {alpha}6{beta}1 Binding Site in the Angiogenic Inducer CCN1 (CYR61). J. Biol. Chem. 278: 33801-33808 [Abstract] [Full Text]  
• He, S., Jin, M. L., Worpel, V., Hinton, D. R. (2003). A Role for Connective Tissue Growth Factor in the Pathogenesis of Choroidal Neovascularization. Arch Ophthalmol 121: 1283-1288 [Abstract] [Full Text]  
• Schober, J. M., Lau, L. F., Ugarova, T. P., Lam, S. C.-T. (2003). Identification of a Novel Integrin {alpha}M{beta}2 Binding Site in CCN1 (CYR61), a Matricellular Protein Expressed in Healing Wounds and Atherosclerotic Lesions. J. Biol. Chem. 278: 25808-25815 [Abstract] [Full Text]  
• Ratcliffe, J., Nakanishi, M., Jaffe, R. B. (2003). Identification of Definitive and Fetal Zone Markers in the Human Fetal Adrenal Gland Reveals Putative Developmental Genes. J. Clin. Endocrinol. Metab. 88: 3272-3277 [Abstract] [Full Text]  
• Lin, C. G., Leu, S.-J., Chen, N., Tebeau, C. M., Lin, S.-X., Yeung, C.-Y., Lau, L. F. (2003). CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family. J. Biol. Chem. 278: 24200-24208 [Abstract] [Full Text]  
• Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., Daluiski, A., Lyons, K. M. (2003). Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130: 2779-2791 [Abstract] [Full Text]  
• Perbal, B, Brigstock, D R, Lau, L F (2003). Report on the second international workshop on the CCN family of genes. Mol. Pathol. 56: 80-85 [Abstract] [Full Text]  
• Brigstock, D R, Goldschmeding, R, Katsube, K-i, Lam, S C-T, Lau, L F, Lyons, K, Naus, C, Perbal, B, Riser, B, Takigawa, M, Yeger, H (2003). Proposal for a unified CCN nomenclature. Mol. Pathol. 56: 127-128 [Abstract] [Full Text]  
• Soon, L. L., Yie, T.-A., Shvarts, A., Levine, A. J., Su, F., Tchou-Wong, K.-M. (2003). Overexpression of WISP-1 Down-regulated Motility and Invasion of Lung Cancer Cells through Inhibition of Rac Activation. J. Biol. Chem. 278: 11465-11470 [Abstract] [Full Text]  
• Mo, F.-E, Muntean, A. G., Chen, C.-C., Stolz, D. B., Watkins, S. C., Lau, L. F. (2002). CYR61 (CCN1) Is Essential for Placental Development and Vascular Integrity. Mol. Cell. Biol. 22: 8709-8720 [Abstract] [Full Text]  
• Leu, S.-J., Lam, S. C.-T., Lau, L. F. (2002). Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins alpha vbeta 3 and alpha 6beta 1 in Human Umbilical Vein Endothelial Cells. J. Biol. Chem. 277: 46248-46255 [Abstract] [Full Text]  
• McCaig, C., Perks, C. M., Holly, J. M. P. (2002). Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J. Cell Sci. 115: 4293-4303 [Abstract] [Full Text]  
• Hu, Y., Ippolito, J. E., Garabedian, E. M., Humphrey, P. A., Gordon, J. I. (2002). Molecular Characterization of a Metastatic Neuroendocrine Cell Cancer Arising in the Prostates of Transgenic Mice. J. Biol. Chem. 277: 44462-44474 [Abstract] [Full Text]  
• Chaqour, B., Whitbeck, C., Han, J.-S., Macarak, E., Horan, P., Chichester, P., Levin, R. (2002). Cyr61 and CTGF are molecular markers of bladder wall remodeling after outlet obstruction. Am. J. Physiol. Endocrinol. Metab. 283: E765-E774 [Abstract] [Full Text]  
• Sakamoto, K., Yamaguchi, S., Ando, R., Miyawaki, A., Kabasawa, Y., Takagi, M., Li, C. L., Perbal, B., Katsube, K.-i. (2002). The Nephroblastoma Overexpressed Gene (NOV/ccn3) Protein Associates with Notch1 Extracellular Domain and Inhibits Myoblast Differentiation via Notch Signaling Pathway. J. Biol. Chem. 277: 29399-29405 [Abstract] [Full Text]  
• Li, C L, Martinez, V, He, B, Lombet, A, Perbal, B (2002). A role for CCN3 (NOV) in calcium signalling. Mol. Pathol. 55: 250-261 [Abstract] [Full Text]  
• Hilfiker, A., Hilfiker-Kleiner, D., Fuchs, M., Kaminski, K., Lichtenberg, A., Rothkotter, H.-J., Schieffer, B., Drexler, H. (2002). Expression of CYR61, an Angiogenic Immediate Early Gene, in Arteriosclerosis and Its Regulation by Angiotensin II. Circulation 106: 254-260 [Abstract] [Full Text]  
• Moussad, E E-D A, Rageh, M A E, Wilson, A K, Geisert, R D, Brigstock, D R (2002). Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor {beta} type 1 (TGF-{beta}1) at the utero-placental interface during early pregnancy in the pig. Mol. Pathol. 55: 186-192 [Abstract] [Full Text]  
• Manara, M. C., Perbal, B., Benini, S., Strammiello, R., Cerisano, V., Perdichizzi, S., Serra, M., Astolfi, A., Bertoni, F., Alami, J., Yeger, H., Picci, P., Scotlandi, K. (2002). The Expression of ccn3(nov) Gene in Musculoskeletal Tumors. Am. J. Pathol. 160: 849-859 [Abstract] [Full Text]  
• Desnoyers, L., Arnott, D., Pennica, D. (2001). WISP-1 Binds to Decorin and Biglycan. J. Biol. Chem. 276: 47599-47607 [Abstract] [Full Text]  
• Gupta, N, Wang, H, McLeod, T L, Naus, C C G, Kyurkchiev, S, Advani, S, Yu, J, Perbal, B, Weichselbaum, R R (2001). Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol. Pathol. 54: 293-299 [Abstract] [Full Text]